PPAR-α activation required for decreased glucose uptake and increased susceptibility to injury during ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 6 57-6, 2005, Pages

  Panagia, Marcello ^a   Gibbons, Geoffrey F ^b   Radda, George K ^a   Clarke, Kieran ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Diabetic mouse heart; GLUT 4

Indexed keywords

FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVATION; ENZYME REGULATION; FATTY ACID BLOOD LEVEL; GLUCOSE TRANSPORT; HEART INJURY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DISEASE SUSCEPTIBILITY; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HEART RATE; INSULIN; MICE; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; PPAR ALPHA;

EID: 19344362320     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00200.2004     Document Type: Article

References (36)

1. Aasum E, Hafstad AD, Severson DL, and Larsen TS. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52: 434-411, 2003.
2. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, and Gonzalez FJ. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem 273: 5678-5684, 1998.
3. Barger PM and Kelly DP. PPAR signalling in the control of cardiac energy metabolism. Trends Cardiovasc Med 10: 238-245, 2000.
4. Belke DD, Larsen TS, Gibbs EM, and Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 279: E1104-E1113, 2000.
5. Boden G and Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 32: 14-23, 2002.
6. Campbell FM, Kozak R, Wagner A, Altarejos JY, Dyck JRB, Belke DD, Severson DL, Kelly DP, and Lopaschuk GD. A role for peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac malonyl-CoA levels. J Biol Chem 277: 4098-4103, 2002.
7. Chatham JC and Seymour AML. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res 55: 104-112, 2002.
8. Cross HR, Opie LH, Radda GK, and Clarke K. Is a high glycogen content beneficial or detrimental to the ischaemic rat heart? A controversy resolved. Circ Res 78: 482-491, 1996.
9. 87Rb NMR spectroscopic study. Magn Reson Med 34: 673-685. 1995.
10. Depre C, Vanoverschelde JLJ, and Taegtmeyer H. Glucose for the heart. Circulation 99: 578-588, 1999.
11. Depre C, Young ME, Ying J, Ahuja HS, Han Q, Garza N, Davies PJA, and Taegtmeyer H. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 32: 985-996, 2000.
12. Desrois M, Sidell RJ, Gauguier D, Davey CL, Radda GK, and Clarke K. Gender differences in hypertrophy, insulin resistance and ischemic injury in the aging type 2 diabetic rat heart. J Mol Cell Cardiol 37: 547-555, 2004.
13. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, and Kelly DP. A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 100: 1226-1231, 2003.
14. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, and Kelly DP. The cardiac phenotype induced by PPARa overexpression mimics that caused by diabetes mellitus. J Clin Invest 109: 121-130, 2002.
15. Huss JM and Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res 95: 568-578, 2004.
16. Ingwall JS. Transgenesis and cardiac energetics: new insights into cardiac metabolism. J Mol Cell Cardiol 37: 613-623, 2004.
17. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, and Wahli W. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 103: 1489-1498, 1999.
18. King LM and Opie LH. Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow. Cardiovasc Res 39: 381-392, 1998.
19. King LM, Sidell RJ, Wilding JR, Radda GK, and Clarke K. Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia. Am J Physiol Heart Circ Physiol 280: H1173-H1181, 2001.
20. Leone TC, Weinheimer CJ, and Kelly DP. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96: 7473-7478, 1999.
21. Lopaschuk GD, Belke DD, Gamble J, Itoi T, and Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276, 1994.
22. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, Way JM, Winegar DA, Corton JC, Dohm GL, and Kraus WE. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knock-out mice. J Biol Chem 277: 26089-26097, 2002.
23. Neitzel AS, Carley AN, and Severson DL. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. Am J Physiol Endocrinol Metab 284: E357-E365, 2003.
24. Randle PJ, Hales CN, Garland PB, and Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
25. Sakamoto J, Barr RL, Kavanagh KM, and Lopaschuk GD. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. Am J Physiol Heart Circ Physiol 278: H1196-H1204, 2000.
26. Scheuermann-Freestone MMP, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, and Clarke K. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107: 3040-3046, 2003.
27. Sidell R, Cole M, Draper N, Desrois M, Buckingham R, and Clarke K. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart. Diabetes 51: 1110-1117, 2002.
28. Stanley WC, Lopaschuk GD, and McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34: 25-33, 1997.
29. Sugden MC, Bulmer K, Gibbons GF, Knight BL, and Holness JJ. Peroxisome-proliferator-activated receptor-α (PPARα) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Biochem J 364: 361-368, 2002.
30. Tian R and Abel ED. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 103: 2961-2966, 2001.
31. 2+-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51: 1166-1171, 2002.
32. Van der Lee KAJM, Willemsen PHM, Samec S, Seydoux J, Dulloo AG, Pelsers MMAL, Glatz JFC, Van der Vusse GJ, and Van Bilsen M. Fasting-induced changes in the expression of genes controlling substrate metabolism in the rat heart. J Lipid Res 42: 1752-1758, 2001.
33. Wall SR and Lopaschuk GD. Glucose oxidation rates in fatty-acid perfused isolated working hearts from diabetic rat. Biochim Biophys Acta 1006: 97-103, 1989.
34. Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, Ono T, Hasegawa G, Naito M, Nakajima T, Kamijo Y, Gonzalez FJ, and Aoyama T. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with age-dependent cardiac toxicity. J Biol Chem 275: 22293-22299, 2000.
35. 2+ transport. Circ Res 77: 88-97, 1995.
36. Young LH, Renfu Y, Russell R, Hu X, Caplan M, Ren J, Shulman GI, and Sinusas AJ. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95: 415-422, 1997.